In a patient taking furosemide 20 mg daily and lisinopril 20 mg daily who still has elevated blood pressure, what is the appropriate next step in antihypertensive management?

Add a Calcium Channel Blocker (CCB) to the Current Regimen

For a patient on lisinopril 20 mg and furosemide 20 mg daily with persistently elevated blood pressure, the next step is to add a dihydropyridine calcium channel blocker (such as amlodipine) to the regimen. 1

Rationale Based on Current Guidelines

The 2020 International Society of Hypertension guidelines provide a clear algorithmic approach for non-Black patients with uncontrolled hypertension 1:

Step-by-Step Treatment Algorithm for Non-Black Patients:

1. Step 1: Low-dose ACE inhibitor/ARB (✓ already done - lisinopril 20 mg)
2. Step 2: Add DHP-CCB
3. Step 3: Increase to full doses
4. Step 4: Add thiazide/thiazide-like diuretic
5. Step 5: Add spironolactone or alternatives

Your patient is currently on Step 1 (ACE inhibitor) plus a loop diuretic (furosemide). The guideline-recommended progression is to add a calcium channel blocker before increasing doses or adding additional agents. 1

Why CCB Before Optimizing Current Medications?

The evidence strongly supports combination therapy with complementary mechanisms rather than maximizing single agents 2, 3. The combination of ACE inhibitor + CCB:

• Provides additive blood pressure reduction through different mechanisms (RAAS blockade + vasodilation)
• Reduces cardiovascular events more effectively than dose escalation of monotherapy 4
• Minimizes side effects compared to high-dose monotherapy 5

Important Considerations About the Current Furosemide

Loop diuretics like furosemide are NOT first-line for essential hypertension. 6 The FDA labeling indicates furosemide 20 mg is a relatively low dose, and the guidelines consistently recommend thiazide or thiazide-like diuretics over loop diuretics for hypertension management 1, 7.

However, if this patient has:

• Heart failure with volume overload - continue furosemide 8, 7
• Chronic kidney disease with eGFR <30 - loop diuretics are appropriate 8
• Simple hypertension without these conditions - consider switching to a thiazide-like diuretic (chlorthalidone or indapamide) when adding the CCB

Specific Dosing Recommendations

Add amlodipine 5 mg daily (can titrate to 10 mg if needed) 1

Alternative CCBs include:

• Nifedipine extended-release 30-60 mg daily
• Felodipine 5-10 mg daily

Target Blood Pressure

Aim for <130/80 mmHg in most patients, or <140/90 mmHg minimum 1, 7. Achieve target within 3 months of treatment adjustment 1.

Critical Pitfalls to Avoid

1. Don't just increase lisinopril dose alone - ACE inhibitors have a flat dose-response curve, meaning higher doses extend duration but don't substantially increase potency 3

2. Check medication adherence first - before adding agents, confirm the patient is actually taking the current medications 1

3. Verify proper blood pressure measurement - confirm elevated readings with home BP monitoring (≥135/85 mmHg) or ambulatory monitoring (≥130/80 mmHg) 1

4. Screen for secondary hypertension if BP remains uncontrolled despite appropriate therapy 1

If Blood Pressure Remains Elevated After Adding CCB

Following the ISH algorithm 1:

• Next step: Increase both lisinopril and CCB to full doses
• Then: Add a thiazide-like diuretic (chlorthalidone 12.5-25 mg or indapamide 1.25-2.5 mg)
• Resistant hypertension: Add spironolactone 25-50 mg if still uncontrolled on three agents 7

The 2024 ESC guidelines 7 and 2025 AHA/ACC guidelines 9 align with this stepwise approach, emphasizing that most patients require 2-3 antihypertensive agents from different classes to achieve adequate control.